{"id":"https://openalex.org/W2886237188","doi":"https://doi.org/10.1158/1557-3125.advbc17-ia22","title":"Abstract IA22: Integrating immunotherapy and targeted therapy in breast cancer","display_name":"Abstract IA22: Integrating immunotherapy and targeted therapy in breast cancer","publication_year":2018,"publication_date":"2018-08-01","ids":{"openalex":"https://openalex.org/W2886237188","doi":"https://doi.org/10.1158/1557-3125.advbc17-ia22","mag":"2886237188"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3125.advbc17-ia22","doi":"https://doi.org/10.1158/1557-3125.advbc17-ia22","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.advbc17-ia22","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043714628","display_name":"Jean J. Zhao","orcid":"https://orcid.org/0000-0002-4561-5688","observed_orcids":["https://orcid.org/0000-0002-4561-5688"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jean Zhao","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5043714628"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"8_Supplement","first_page":"IA22","last_page":"IA22"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.03460000082850456,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.019300000742077827,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.800000011920929},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.8130000233650208},{"id":"https://openalex.org/keywords/pi3k-inhibition","display_name":"PI3K inhibition","score":0.6209999918937683},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.9800000190734863},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9710000157356262},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6600000262260437},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.8339999914169312},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.7649999856948853},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.5189999938011169},{"id":"https://openalex.org/keywords/met-amplification","display_name":"MET amplification","score":0.6679999828338623},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.7699999809265137},{"id":"https://openalex.org/keywords/ras-mutations","display_name":"RAS mutations","score":0.8159999847412109},{"id":"https://openalex.org/keywords/ctnnb1-mutation","display_name":"CTNNB1 mutation","score":0.875},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7850000262260437},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.9319999814033508},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.8299999833106995},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.953000009059906},{"id":"https://openalex.org/keywords/genetically-engineered-mouse-models","display_name":"genetically engineered mouse models","score":0.9240000247955322},{"id":"https://openalex.org/keywords/pik3ca","display_name":"PIK3CA","score":0.8299999833106995},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8889999985694885}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6964520812034607},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6614008545875549},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6269716620445251},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6213403344154358},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.5833871364593506},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5783886313438416},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5148250460624695},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.4842959940433502},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.44610515236854553},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.41923901438713074},{"id":"https://openalex.org/C2778472372","wikidata":"https://www.wikidata.org/wiki/Q7833138","display_name":"Trametinib","level":4,"score":0.41758227348327637},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3468039631843567},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.2933892607688904},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27106475830078125},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2173166275024414},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14360636472702026},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10424956679344177},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3125.advbc17-ia22","doi":"https://doi.org/10.1158/1557-3125.advbc17-ia22","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.advbc17-ia22","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2612523995","https://openalex.org/W7162307117","https://openalex.org/W3112290174","https://openalex.org/W4379375382","https://openalex.org/W4232629473","https://openalex.org/W2564262167","https://openalex.org/W4285299659","https://openalex.org/W2056427943","https://openalex.org/W2158936191","https://openalex.org/W4230445265"],"abstract_inverted_index":{"Abstract":[0],"Therapeutic":[1],"resistance":[2,40,72,82,203],"is":[3,114],"a":[4,87],"major":[5],"obstacle":[6],"in":[7,60,138,222,234],"the":[8,68,118,130,160,210,229],"clinic":[9],"for":[10,146],"cancer":[11,22,167,224],"treatment.":[12],"Utilizing":[13],"our":[14],"novel":[15,166],"genetically":[16],"engineered":[17],"mouse":[18],"models":[19,190],"(GEMMs)":[20],"of":[21,27,54,67,110,120,132,228],"driven":[23],"by":[24,117],"inducible":[25],"expression":[26],"oncogenic":[28],"PIK3CA":[29],"or":[30,44],"HER2,":[31],"coupled":[32],"with":[33,135,140,148,172],"pharmacologic":[34],"approaches,":[35],"we":[36,49,96,157,186],"identified":[37,78],"several":[38],"significant":[39],"mechanisms":[41],"to":[42,73,83,129,155,162,191,201,205,209],"PI3K-":[43],"HER2-targeted":[45,84,141],"therapy.":[46],"For":[47],"example,":[48],"found":[50,97],"spontaneous":[51],"focal":[52],"amplification":[53],"Met":[55],"and":[56,62,64,104,143,164,199,204,219],"Myc,":[57],"recurrent":[58],"mutations":[59],"Ras":[61],"\u03b2-catenin,":[63],"compensatory":[65],"activation":[66],"MAPK":[69],"pathway":[70],"render":[71],"PI3K":[74],"inhibition.":[75],"We":[76],"recently":[77],"Cyclin":[79],"D1-CDK4":[80],"mediated":[81],"therapy":[85,142,198,221],"through":[86],"signaling":[88],"feedback":[89],"loop.":[90],"Beyond":[91],"suppressing":[92],"cell":[93],"cycle":[94],"progression,":[95],"that":[98,195],"CDK4/6":[99,136],"inhibitors":[100],"promote":[101],"antitumor":[102],"immunity":[103],"increase":[105],"cytotoxic":[106],"T":[107],"cell-mediated":[108],"clearance":[109],"tumor":[111],"cells,":[112],"which":[113],"further":[115],"enhanced":[116],"addition":[119],"immune":[121],"checkpoint":[122],"blockade.":[123],"More":[124],"importantly,":[125],"these":[126,189,207],"results":[127],"led":[128,159],"design":[131],"clinical":[133,180,211],"trials":[134],"inhibitor":[137],"combination":[139],"PD1":[144],"blockade":[145],"patients":[147],"metastatic,":[149],"refractory":[150],"HER2+":[151],"breast":[152,223],"cancer.":[153],"Parallel":[154],"GEMMs,":[156],"have":[158,187],"efforts":[161],"establish":[163],"characterize":[165],"patient-derived":[168],"xenograft":[169],"(PDX)":[170],"models,":[171],"an":[173,178],"emphasis":[174],"on":[175],"brain":[176],"metastases,":[177],"emerging":[179],"challenge.":[181],"I":[182],"will":[183],"discuss":[184],"how":[185],"used":[188],"discover":[192],"therapeutic":[193],"strategies":[194],"integrate":[196],"targeted":[197,220],"immunotherapy":[200,218],"overcome":[202],"drive":[206],"discoveries":[208],"trials.":[212],"Citation":[213],"Format:":[214],"Jean":[215],"Zhao.":[216],"Integrating":[217],"[abstract].":[225],"In:":[226],"Proceedings":[227],"AACR":[230],"Special":[231],"Conference:":[232],"Advances":[233],"Breast":[235],"Cancer":[236,247],"Research;":[237],"2017":[238],"Oct":[239],"7-10;":[240],"Hollywood,":[241],"CA.":[242],"Philadelphia":[243],"(PA):":[244],"AACR;":[245],"Mol":[246],"Res":[248],"2018;16(8_Suppl):Abstract":[249],"nr":[250],"IA22.":[251]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2018-08-22T00:00:00"}